Xuemei Yu

863 total citations
29 papers, 658 citations indexed

About

Xuemei Yu is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Xuemei Yu has authored 29 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Xuemei Yu's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Diabetes and associated disorders (4 papers) and Diabetes Treatment and Management (4 papers). Xuemei Yu is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Diabetes and associated disorders (4 papers) and Diabetes Treatment and Management (4 papers). Xuemei Yu collaborates with scholars based in China, United States and Hong Kong. Xuemei Yu's co-authors include Jing Xiao, Honghong Tan, Lin Jiang, Xiaojun Yang, Juan Feng, Yuliang Feng, Yu Pan, Peihong Chen, Hua Jin and Lili Yang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Xuemei Yu

27 papers receiving 654 citations

Peers

Xuemei Yu

CCM

EDM

PHYSI

Sharon Li Ting Pek Singapore

Ming-Hui Zheng China

Pippa F. Cosper United States

Lian Xu China

Zhe Wei China

Gerlinde Trischler Germany

Xue Hong China

Joanna Kontaraki Greece

Maria T. K. Zaldivia Australia

Rulin Zhuang China

Sharon Li Ting Pek Singapore

Xuemei Yu

394 ×1.2

325 ×1.6

196 ×1.2

CCM

125 ×1.0

EDM

103 ×0.9

PHYSI

Citations per year, relative to Xuemei Yu Xuemei Yu (= 1×) peers Sharon Li Ting Pek

Countries citing papers authored by Xuemei Yu

Since Specialization

Citations

This map shows the geographic impact of Xuemei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Yu more than expected).

Fields of papers citing papers by Xuemei Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Yu. The network helps show where Xuemei Yu may publish in the future.

Co-authorship network of co-authors of Xuemei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemei Yu. A scholar is included among the top collaborators of Xuemei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemei Yu. Xuemei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Xuemei, Jiao Sun, Min Zhang, et al.. (2025). Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes. Drug Design Development and Therapy. Volume 19. 1795–1808.

Yu, Xuemei, et al.. (2025). Islet organoids: a new hope for islet transplantation in diabetes. Frontiers in Immunology. 15. 1540209–1540209. 3 indexed citations

Yu, Xuemei, et al.. (2024). Pterostilbene ameliorates streptozotocin-induced gestational diabetes mellitus via alteration of oxidative stress, apoptosis and inflammation. Materials Express. 14(2). 321–328.

An, Qi, et al.. (2023). Comparative Study on Socio-Spatial Structures of the Typical Plain Cities of Chengdu and Beijing in Transitional China. Sustainability. 15(5). 4364–4364. 2 indexed citations

Yu, Xuemei, et al.. (2023). Intermittent versus continuous control of tracheal cuff pressure in patients undergoing mechanical ventilation: A systematic review and meta‐analysis. Journal of Clinical Nursing. 32(15-16). 4283–4294. 1 indexed citations

Zhang, Shan, et al.. (2022). Circulating spexin levels are influenced by the glycemic status and correlated with pancreatic β-cell function in Chinese subjects. Acta Diabetologica. 60(2). 305–313. 9 indexed citations

Jin, Hua, Peihong Chen, Shan Zhang, Ping Wu, & Xuemei Yu. (2022). Iron Metabolism Markers and Lower Extremity Arterial Disease in People with Type 2 Diabetes. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3103–3110. 2 indexed citations

Lü, Jun, et al.. (2021). The protective role of serum uric acid against premature membrane rupture in gestational diabetes: a cross-sectional study. BMC Endocrine Disorders. 21(1). 95–95. 7 indexed citations

Luo, Mingjuan, et al.. (2020). Nerve growth factor is closely related to glucose metabolism, insulin sensitivity and insulin secretion in the second trimester: a case–control study in Chinese. Nutrition & Metabolism. 17(1). 98–98. 7 indexed citations

10.

Lu, Jun, et al.. (2019). Association between Pancreatic Atrophy and Loss of Insulin Secretory Capacity in Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2019. 1–6. 14 indexed citations

11.

Liu, Haijun, et al.. (2019). Alterations of DNA methylation profile in proximal jejunum potentially contribute to the beneficial effects of gastric bypass in a diabetic rat model. Surgery for Obesity and Related Diseases. 15(8). 1291–1298. 1 indexed citations

12.

Lu, Jun, et al.. (2018). HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study. Diabetes Therapy. 9(1). 209–217. 14 indexed citations

13.

Zhao, Li, Jing Cheng, Yingchao Chen, et al.. (2017). Serum alanine aminotransferase/aspartate aminotransferase ratio is one of the best markers of insulin resistance in the Chinese population. Nutrition & Metabolism. 14(1). 64–64. 37 indexed citations

14.

Jin, Hua, et al.. (2017). Increased serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with glucose metabolism in Chinese pregnant women. Journal of Endocrinological Investigation. 41(6). 663–670. 8 indexed citations

15.

Xiao, Jing, Yu Pan, Xiaojun Yang, et al.. (2016). Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death and Disease. 7(6). e2277–e2277. 306 indexed citations

16.

Zhang, Shan, Lili Yang, Peihong Chen, et al.. (2016). Circulating Adipocyte Fatty Acid Binding Protein (FABP4) Levels Are Associated with Irisin in the Middle-Aged General Chinese Population. PLoS ONE. 11(1). e0146605–e0146605. 10 indexed citations

17.

Gao, Ting, et al.. (2015). Associations of betatrophin levels with irisin in Chinese women with normal glucose tolerance. Diabetology & Metabolic Syndrome. 7(1). 26–26. 35 indexed citations

18.

Gao, Ting, Kairui Jin, Hua Jin, et al.. (2015). Circulating Betatrophin Correlates with Triglycerides and Postprandial Glucose among Different Glucose Tolerance Statuses—A Case-Control Study. PLoS ONE. 10(8). e0133640–e0133640. 48 indexed citations

19.

Yu, Xuemei, et al.. (2014). Clinical study of exercise on improvement of β-cell function and insulin resistance in non-diabetic young offsprings of diabetic patients. Journal of Endocrinological Investigation. 37(4). 353–358. 1 indexed citations

20.

Yu, Xuemei, Peihong Chen, Hongtao Wang, & Tong Zhu. (2012). Pioglitazone Ameliorates Endothelial Dysfunction in Those with Impaired Glucose Regulation among the First-Degree Relatives of Type 2 Diabetes Mellitus Patients. Medical Principles and Practice. 22(2). 156–160. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact